NEW YORK (
CHANGE IN RATINGS
was upgraded at Robert Baird to outperform from neutral. $620 price target. 2014 holds more promise for the company, Robert Baird said.
was downgraded to hold at TheStreet Ratings.
was downgraded at Bank of America/Merrill Lynch to underperform from buy. Valuation call, based on a $42 price target, Bank of America/Merrill said.
was downgraded at Keybanc to hold from buy. Estimates were also cut, as the company lacks near-term catalysts, Keybanc said.
was upgraded to buy at TheStreet Ratings.
was upgraded at Goldman Sachs to buy. $45 price target. Stock has pulled back to an attractive entry point and growth is not likely to slow significantly, Goldman Sachs said.
was downgraded at FIG Partners to market perform. $16 price target. Company is facing higher costs, FIG Partners said.
was upgraded at Sterne Agee to buy. Company is cutting costs, and the earnings bar has been reset to a more reasonable level, Sterne Agee said.
was downgraded at Credit Suisse to neutral from outperform. Valuation call, based on a $23 price target, Credit Suisse said.
was downgraded at Sterne Agee to neutral from buy. Valuation call, as the stock moved through the $28 price target, Sterne Agee said.
Stock Comments/EPS Changes
Apple numbers were raised at J.P. Morgan. Shares are now seen reaching $600. Estimates were also increased through 2014 on strong quarterly results. Overweight rating.
Apple numbers were raised at Barclays. Shares are now seen reaching $585. Estimates were also increased on strong quarterly results, Barclays said. Overweight rating.
price target, estimates were raised at UBS. Healthsouth lifted its estimates across the board. Higher revenue and favorable workers comp reversal drive upside, UBS said. $35.50 price target and neutral rating.
estimates, price target were lifted at UBS. The company continues to outgrow the industry and return cash to shareholders, UBS said. $34 price target and buy rating.
numbers were cut at Barclays. Shares are now seen reaching $131. Estimates were also lowered on difficult quarter and lowered outlook, Barclays said. Overweight rating.
Simon Property Group
estimates, price target were increased at Jefferies. Company's portfolio and dominant market position enable it to generate healthy lease spreads, Jefferies said. $180 price target and buy rating.
Read: How to Ace a Car Dealership Test Drive
estimates, price target were lowered at Jefferies. Company-store sale expectations have been lowered, Jefferies said. $63 price target and hold rating.
>To submit a news tip, email:
and become a fan on
This article was written by a staff member of TheStreet.